Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.5K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.5K
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

686
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
686
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

384
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
384

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with women's choice for mode of cervical sampling in future cervical cancer screening.

PloS one·2026
Same author

Corrigendum to 'Performance of FIT-based colorectal cancer screening in Denmark from 2014 to 2022' [Eur J Cancer 241 (June)(2026) 116788].

European journal of cancer (Oxford, England : 1990)·2026
Same author

Performance of FIT-based colorectal cancer screening in Denmark from 2014 to 2022.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Health Care Policy Implementation Trial of Primary Human Papillomavirus-Based Cervical Screening in Denmark.

International journal of cancer·2026
Same author

Women's preferences for cervical cancer screening methods: a discrete choice experiment in Estonia and France.

BMC women's health·2026
Same author

Nationwide Study on the Cervical Cancer Screening Pathway in Estonia.

International journal of cancer·2026

Related Experiment Video

Updated: Mar 15, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.3K

Screening for genital chlamydia infection.

Nicola Low1, Shelagh Redmond, Anneli Uusküla

  • 1Institute of Social and Preventive Medicine (ISPM), University of Bern, Finkenhubelweg 11, Bern, Switzerland, CH-3012.

The Cochrane Database of Systematic Reviews
|September 14, 2016
PubMed
Summary
This summary is machine-generated.

Chlamydia screening in women shows moderate evidence of reducing pelvic inflammatory disease (PID) risk. However, evidence on transmission reduction and effects in pregnancy remains limited, necessitating further research.

More Related Videos

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.4K
Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.6K

Related Experiment Videos

Last Updated: Mar 15, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.3K
A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.4K
Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.6K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Chlamydia trachomatis is the most common bacterial STI globally.
  • Screening sexually active young adults can reduce transmission and prevent complications like PID.
  • PID can lead to tubal infertility and ectopic pregnancy in women.

Purpose of the Study:

  • To evaluate the impact and safety of chlamydia screening versus standard care.
  • To assess effects on transmission and infection complications in pregnant and non-pregnant women and men.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) and non-randomized trials.
  • Searched multiple electronic databases and clinical trial registries.
  • Data extracted and analyzed using meta-analysis with a fixed-effect model.

Main Results:

  • Moderate evidence suggests chlamydia screening reduces PID risk in women (RR 0.68, 95% CI 0.49 to 0.94).
  • Low-quality evidence on transmission reduction; one trial showed reduced prevalence in female sex workers.
  • Very low-quality evidence for reduced epididymitis risk in men; no RCTs on screening in pregnancy.

Conclusions:

  • Chlamydia screening offers moderate evidence for reducing PID in women.
  • Low-quality evidence exists for transmission reduction; further research is needed.
  • No RCT evidence on chlamydia screening during pregnancy; future trials are recommended.